Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Singh Shawn received 36,818 Vistagen Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 30, 2026 · Filed Jul 2, 2026
On Jun 30, 2026, Singh Shawn (Director, President and CEO) received 36,818 Vistagen Therapeutics, Inc. shares as an award at US$0.19 for US$6,995, leaving 54,846 shares. Filed Jul 2, 2026 (Form 4).
- Awarded
- 36,818 shares
- Price
- US$0.19
- Value
- US$6,995
- Holding after
- 54,846 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Stock | Award | 36,818 | US$0.19 | 54,846 | Direct |
Source
Related
- Vistagen Therapeutics, Inc.
- Singh Shawn
- Vistagen Therapeutics, Inc. shareholders
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Commodore Capital LP · Aug 14, 2026
- Schedule 13G/A · TCG Crossover GP I, LLC · Aug 14, 2026
- Form 4 · Adler Reid G. · Jul 2, 2026
- Form 4 · Tressler Nick B. · Jul 2, 2026